These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hypertension and fatty liver: guilty by association? Brookes MJ; Cooper BT J Hum Hypertens; 2007 Apr; 21(4):264-70. PubMed ID: 17273155 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Rafiq N; Younossi ZM Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917 [TBL] [Abstract][Full Text] [Related]
8. Review article: diagnosis and treatment of non-alcoholic fatty liver disease. Oh MK; Winn J; Poordad F Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991 [TBL] [Abstract][Full Text] [Related]
9. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Younossi ZM Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557 [TBL] [Abstract][Full Text] [Related]
10. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers. Ahmed MH Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631 [No Abstract] [Full Text] [Related]
11. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. Komatsu M; Yazaki M; Tanaka N; Sano K; Hashimoto E; Takei Y; Song YZ; Tanaka E; Kiyosawa K; Saheki T; Aoyama T; Kobayashi K J Hepatol; 2008 Nov; 49(5):810-20. PubMed ID: 18620775 [TBL] [Abstract][Full Text] [Related]
12. [Prognosis of non-alcoholic fatty liver disease]. Xu YQ Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):689-90. PubMed ID: 17903374 [No Abstract] [Full Text] [Related]
13. Are children after liver transplant more prone to non-alcoholic fatty liver disease? Nobili V; Dhawan A Pediatr Transplant; 2008 Sep; 12(6):611-3. PubMed ID: 18346037 [No Abstract] [Full Text] [Related]
14. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms]. Spahr L; Rubbia-Brandt L; Hadengue A Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004 [TBL] [Abstract][Full Text] [Related]
15. Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure. Canbay A; Bechmann LP; Best J; Jochum C; Treichel U; Gerken G Z Gastroenterol; 2006 Mar; 44(3):245-8. PubMed ID: 16514570 [TBL] [Abstract][Full Text] [Related]
16. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)? Chavez-Tapia NC; Tiribelli C Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116 [No Abstract] [Full Text] [Related]
17. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S; Yukawa T; Uetake S; Yamauchi M Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [TBL] [Abstract][Full Text] [Related]
18. Liver diseases in the elderly: an update. Floreani A Dig Dis; 2007; 25(2):138-43. PubMed ID: 17468549 [TBL] [Abstract][Full Text] [Related]
19. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Schindhelm RK; Diamant M; Dekker JM; Tushuizen ME; Teerlink T; Heine RJ Diabetes Metab Res Rev; 2006; 22(6):437-43. PubMed ID: 16832839 [TBL] [Abstract][Full Text] [Related]
20. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Adams LA; Angulo P Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]